<SEC-DOCUMENT>0001140361-22-025657-index.html : 20220711 <SEC-HEADER>0001140361-22-025657.hdr.sgml : 20220711 <ACCEPTANCE-DATETIME>20220711073837 ACCESSION NUMBER: 0001140361-22-025657 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20220710 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220711 DATE AS OF CHANGE: 20220711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 221075892 BUSINESS ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>ny20004741x1_8k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: ny20004741x1_8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-2.1 <SEQUENCE>2 <FILENAME>ny20004741x1_ex2-1.htm <DESCRIPTION>EXHIBIT 2.1 <TEXT> Document 2 - file: ny20004741x1_ex2-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>3 <FILENAME>ny20004741x1_ex10-1.htm <DESCRIPTION>EXHIBIT 10.1 <TEXT> Document 3 - file: ny20004741x1_ex10-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>ny20004741x1_ex99-1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 4 - file: ny20004741x1_ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>5 <FILENAME>inva-20220710.xsd <DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA <TEXT> Document 5 - file: inva-20220710.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>6 <FILENAME>inva-20220710_lab.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE <TEXT> Document 6 - file: inva-20220710_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>7 <FILENAME>inva-20220710_pre.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE <TEXT> Document 7 - file: inva-20220710_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>ny20004741x1_ex99-1logo1.jpg <TEXT> Document 8 - file: ny20004741x1_ex99-1logo1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>ny20004741x1_ex99-1logo2.jpg <TEXT> Document 9 - file: ny20004741x1_ex99-1logo2.jpg
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>ny20004741x1_8k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: ny20004741x1_8k_htm.html
Document 11 - RAW XML: ny20004741x1_8k_htm.xml
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>12 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>13 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>15 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 15 - file: FilingSummary.html
Document 15 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>17 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 17 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>18 <FILENAME>0001140361-22-025657-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 18 - file: 0001140361-22-025657-xbrl.zip
</DOCUMENT> </SEC-DOCUMENT>